retatrutide ly3437943 triple agonist gip glp-1 glucagon mechanism Beyond GLP -1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon

This is particularly disappointing because, despite being a copper peptide isolate serum with the fewest key ingredients, NIODs product comes in second for the highest cost per mL (Allies of Skins serum comes in first, but closes the gap a bit when the subscription price is lowered after the fifth order)

Each has a different impact on how your body manages its antioxidant levels

From ingredients to side effects, we put these two popular GLP-1 medications head-to-head to help you understand what really sets them apart

PlexusDx also offers the Precision Peptide Genetic Test, which maps 14 metabolic pathways and 49 peptides to reveal how your body responds to weight loss peptides

Nauck MA, Quast DR, Wefers J, Pfeiffer AF

L- ,